Article
Engineered extracellular vesicles targeting BACE1 reduces amyloid-beta plaque formation in a genetic mouse model of Alzheimer’s Disease
2026-08-11
Abstract excerpt
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid-β (Aβ) plaques, neurodegeneration, and cognitive decline. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) catalyzes the rate-limiting step in Aβ production and remains a therapeutic target for AD. However, effective delivery of RNA therapeutics to the brain remains challenging due to the blo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b2ce5835-306b-5922-9212-ebddb83a5720
- DOI
- 10.64898/2026.08.10.744066
